Stay updated on High-Dose Eteplirsen in DMD Clinical Trial
Sign up to get notified when there's something new on the High-Dose Eteplirsen in DMD Clinical Trial page.

Latest updates to the High-Dose Eteplirsen in DMD Clinical Trial page
- ChecktodayChange DetectedThe web page has been updated from version 2.16.2 to version 2.16.3.SummaryDifference0.1%
- Check7 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.1%
- Check15 days agoChange DetectedThe web page has been updated to announce the modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.SummaryDifference1%
- Check22 days agoChange DetectedThe web page has been updated to version 2.16.0, replacing the previous version 2.15.2.SummaryDifference0.2%
- Check44 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check58 days agoChange DetectedThe page has undergone significant changes in the study details for Duchenne Muscular Dystrophy (DMD), including the removal of specific inclusion and exclusion criteria and a revision update from v2.14.4 to v2.15.0.SummaryDifference21%
Stay in the know with updates to High-Dose Eteplirsen in DMD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the High-Dose Eteplirsen in DMD Clinical Trial page.